{
    "2018-02-26": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Why Achillion Pharmaceuticals, Inc. Stock Spiked Today",
                "features": {
                    "keywords": [
                        "Achillion Pharmaceuticals",
                        "Stock Spiked"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "A Deeper Look at Alkermes’ Key Marketed Products",
                "features": {
                    "keywords": [
                        "Alkermes",
                        "Key Marketed Products"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Johnson & Johnson’s Oncology Segment’s Performance in 2017",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Oncology",
                        "Performance"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-27",
                "original_text": "Allergan plc. (AGN) Ex-Dividend Date Scheduled for February 27, 2018",
                "features": {
                    "keywords": [
                        "Allergan",
                        "Ex-Dividend Date"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-24",
                "original_text": "How JNJ’s Hypertension Segment Performed in 4Q17",
                "features": {
                    "keywords": [
                        "JNJ",
                        "Hypertension",
                        "Performance"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-25",
                "original_text": "Johnson & Johnson’s Neuroscience Segment in 2017",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Neuroscience",
                        "Segment"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-26",
                "original_text": "Medtronic's Dominance Results in Wide Moat",
                "features": {
                    "keywords": [
                        "Medtronic",
                        "Dominance",
                        "Wide Moat"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}